Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Troxerutin is a flavonoid derived from rutin and has been used in the management of venous disorders, including varicose veins. Its use is supported by several clinical studies, particularly in Europe and Asia, where it is commonly prescribed for chronic venous insufficiency (CVI) and related symptoms such as pain, swelling, and heaviness in the legs. The proposed mechanisms involve strengthening capillary walls, reducing capillary permeability, and exhibiting anti-inflammatory and antioxidant effects. Randomized controlled trials and meta-analyses have demonstrated that troxerutin can significantly reduce symptoms associated with varicose veins and improve microcirculation. However, while the evidence is promising, it is not as extensive or robust as for some other venoactive agents (such as diosmin or horse chestnut extract). Most studies have moderate sample sizes and variable methodologies, which limits the strength of the overall evidence. Nevertheless, regulatory authorities in several countries recognize troxerutin as a venoactive drug, and it is included in clinical guidelines for CVI in some regions. In summary, the use of troxerutin for varicose veins is scientifically validated to a moderate degree, although larger and more rigorous trials would further clarify its efficacy and optimal usage.

More about Troxerutin
More about Varicose Veins

Other ingredients used for Varicose Veins

Other health conditions supported by Troxerutin

Products containing Troxerutin